arrow
S

Sharon A. Savage

national cancer institute national institutes of health
H指数:76
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detailed Assessment of Rare and Common TERT Variation in a Family with a Telomere Biology Disorder

对一家有端粒生物学疾病家族中罕见和常见TERT变异的详细评估

2025-10-250
OAAI
A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome

一种基于贝叶斯定量分析的基因特异性变异分类方法:更新的专家小组建议改进了TP53生殖细胞变异在Li-Fraumeni综合征中的分类

2025-10-240
OAAI
Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders

MUTYH中的生殖系致病性变异与血液恶性肿瘤或疾病患者造血细胞移植后较差的生存率相关

2025-10-030
OAAI
Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriers

外周血DNA甲基化预测TP53突变携带者中主肿瘤的早期发生

2025-08-260
OAAI
Loss of Ten1 in mice induces telomere shortening and models human dyskeratosis congenita

Ten1在小鼠中的缺失诱导端粒缩短,并模拟人类先天性角化不良

2025-04-110
OA
Risk of therapy-related subsequent cancers in individuals with germline TP53 variants
2024-09-050
PRE
Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group
2024-08-271
OA
Hemophagocytic Lymphohistiocytosis Gene Variants in Severe Aplastic Anemia and Their Impact on Hematopoietic Cell Transplantation Outcomes

重型再生障碍性贫血的噬血细胞淋巴组织细胞增生症基因变异及其对造血细胞移植结局的影响

2024-08-010
PRE
Liver disease and transplantation in telomere biology disorders: An international multicenter cohort
2024-07-010
OAAI
A polymorphic TERT tandem repeat creating an expandable intronic G4 quadruplex is associated with TERT expression, relative leukocyte telomere length and cancer risk

产生可扩展内含子G4四链体的多态性TERT串联重复序列与TERT表达,相对白细胞端粒长度和癌症风险相关

2024-03-220
PRE
Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients
2024-03-220
PRE